Cabiralizumab Biosimilar – Anti-CSF1R, CD115 mAb – Research Grade

Reference:
Product nameCabiralizumab Biosimilar - Anti-CSF1R, CD115 mAb - Research Grade
SourceCAS 1613144-80-1
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsCabiralizumab,FPA-008,CSF1R, CD115,anti-CSF1R, CD115
ReferencePX-TA1408
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Cabiralizumab Biosimilar - Anti-CSF1R/CD115 mAb - Research Grade

General information on Anti-CSF1R/CD115[Homo sapiens] (Cabiralizumab) Monoclonal Antibody

Cabiralizumab is investigated for the treatment of Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Cabiralizumab Biosimilar – Anti-CSF1R, CD115 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human CD115 / CSF1R recombinant protein
Antigen

Human CD115 / CSF1R recombinant protein

PX-P6053 404$
Human IgG4 Isotype Control antibody
Isotype Control

Human IgG4 Isotype Control antibody

PTX17887 189$
Stable Isotope Labelled Cabiralizumab Biosimilar – Anti-CSF1R/CD115 mAb – Research Grade
SIL

Stable Isotope Labelled Cabiralizumab Biosimilar – Anti-CSF1R/CD115 mAb – Research Grade

PX-TA1408-SIL 15750$
Cabiralizumab ELISA Kit
ELISA

Cabiralizumab ELISA Kit

KPTX155 1365$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products